In a recent development, the U.S. Food and Drug Administration (FDA) has announced an extension... (3 revisions)
In a recent development, the Medical Imaging Drugs Advisory Committee (MIDAC) of the U.S Food... (3 revisions)
In a study conducted by the U.S. Food and Drug Administration (FDA), it was found that most... (3 revisions)
The North American Renderers Association (NARA) is urging the US Environmental Protection Agency... (4 revisions)
In a recent article by Emma Rumney on Investing.com, it is reported that nicotine alternatives... (5 revisions)
In a recent development, Ray Starling, former chief of staff to the U.S. Secretary of... (6 revisions)
Consumer Reports, a renowned consumer watchdog, has recently identified high levels of lead and... (8 revisions)
The Environmental Protection Agency (EPA) is celebrating the 50th anniversary of the Safe... (9 revisions)
Daré Bioscience, Inc. (NASDAQ:DARE) reported its Q4 2023 earnings, surpassing expectations with... (11 revisions)
In recent years, the United States has become increasingly reliant on Chinese pharmaceuticals,... (12 revisions)
Amylyx Pharmaceuticals' ALS drug, Relyvrio, has failed in a Phase III trial, showing no efficacy... (12 revisions)
A new antibiotic called ceftobiprole, developed by Basilea Pharmaceutica, has been approved by... (13 revisions)
A recent decision by the Food and Drug Administration (FDA) has denied approval for MDMA therapy... (15 revisions)
In a significant development for both technology and healthcare, Apple has received FDA approval... (15 revisions)
On December 2, 2024, the U.S. Supreme Court heard arguments concerning a legal challenge from... (16 revisions)
In a significant public health decision, the U.S. Food and Drug Administration (FDA) has... (16 revisions)
The U.S. Food and Drug Administration (FDA) has recently made several significant approvals in... (17 revisions)
Novavax, a pharmaceutical company, is awaiting a decision from the US Food and Drug... (20 revisions)
On January 30, 2025, the FDA approved Vertex Pharmaceuticals' Journavx (suzetrigine) for... (22 revisions)
Sage Therapeutics Inc. (NASDAQ:SAGE) saw its shares soar over 45% to $8.09 following a... (29 revisions)
In a significant development for U.S. healthcare, President-elect Donald Trump has nominated... (31 revisions)
In June 2024, the U.S. Supreme Court made a landmark decision to overrule the Chevron deference,... (34 revisions)